August 04, 2021
As cited by the research report titled ‘U.S. Minoxidil Market Size By Product (5%, 2%), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Industry Analysis Report, Country Outlook, Application Development Potential, Price Trend, Competitive Market Share & Forecast, 2021 – 2027’, available with Market Study Report, the U.S. minoxidil market is projected to expand significantly over 2021-2027.
Changing lifestyle, growing incidence of alopecia, increased stress levels, prevalence of emotional shock & depression, and consumption of diet with low protein & iron content are the factors driving the U.S. minoxidil market growth. Moreover, other health issues like cardiovascular diseases, gout, arthritis, cancer, high blood pressure that result into hair loss problems in patients are likely to augment the demand for minoxidil across the region.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3692080/
For the record, minoxidil is an over-the-counter medicine which has been approved by the United States Food & Drug Administration and is used to treat hair loss both by men and women. The product is mainly used to stimulate hair growth or slow down balding. The remedy belongs to a group of drugs known as vasodilators. Minoxidil mainly works by relaxing and enlarging several small blood vessels in human body for an effortless blood flow. This medication works best on people who have been facing hair fall for less than 5 years and are below the age of 40.
According to the American Hair Loss Association, over two-thirds of men experience mild hair loss, mostly at the age of 35 years and by 50 years of age, around 85% of men experience hair thinning and hair loss.
Based on product type, the U.S. minoxidil industry is segmented into 2% minoxidil and 5% minoxidil. As cited in the report, the 5% segment is poised to showcase lucrative growth trends over the analysis period due to its ability to give effective results. As per a study published in the Journal of the American Academy of Dermatology, men who were using 5% minoxidil solution had over 45% new hair growth in comparison to those using 2% minoxidil solution.
Speaking of distribution channel, the marketplace is divided into hospital pharmacies, online pharmacies and retail pharmacies. Among these, retail pharmacies segment is foreseen to record remunerative growth over the forecast period, owing to the affordability and quality of the products.
Prominent players influencing the U.S. minoxidil industry trends are Nanz Medscience Pharma Pvt. Ltd., Walmart Inc., Costco Wholesale Corporation, Renata Limited, Perrigo Company plc, LGM Pharma, Flamma Group, Johnson & Johnson Consumer Inc., Meta Pharmaceutical Ind. S.L., Par Pharmaceutical, and Kumar Organic Products Limited.